Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synchromed II Pump for Hepatic Arterial Infusion in Liver Cancers
NCT04276090Terminated
- Start
- May 2020
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Open-label trial (2 arms). Primary endpoint: Percent Completion of 1st Cycle of Hepatic Artery Chemotherapy at 4 weeks. Started May 2020; status: terminated.
Beyond the preview
Go deeper on NCT04276090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04276090.